FET PET to differentiate between post-treatment changes and recurrence in high-grade gliomas: a single center multidisciplinary clinic controlled study
Ameya D. Puranik,Indraja D. Dev,Venkatesh Rangarajan,Yash Jain,Sukriti Patra,Nilendu C. Purandare,Arpita Sahu,Amitkumar Choudhary,Kajari Bhattacharya,Tejpal Gupta,Abhishek Chatterjee,Archya Dasgupta,Aliasgar Moiyadi,Prakash Shetty,Vikas Singh,Epari Sridhar,Ayushi Sahay,Aekta Shah,Nandini Menon,Suchismita Ghosh,Sayak Choudhury,Sneha Shah,Archi Agrawal,N. Lakshminarayanan,Amit Kumar,Arjun Gopalakrishna
DOI: https://doi.org/10.1007/s00234-024-03495-9
2024-11-13
Neuroradiology
Abstract:The clinico-radiological dilemma in post-treatment high-grade gliomas, between disease recurrence (TR) and treatment-related changes (TRC), still persists. FET (Fluoro-ethyl-tyrosine) PET has been extensively used as problem-solving modality for cases where MR imaging is inconclusive. We incorporated a systematic imaging and clinical follow-up algorithm in a multi-disciplinary clinic (MDC) setting to analyse our cohort of FET PET in post-treatment gliomas.
radiology, nuclear medicine & medical imaging,clinical neurology,neuroimaging